Singapore markets closed

Hofseth BioCare ASA (HBCO.ST)

Stockholm - Stockholm Real-time price. Currency in NOK
Add to watchlist
4.5000-0.2000 (-4.26%)
As of 03:39PM CEST. Market open.
Full screen
Previous close4.7000
Open4.5000
Bid4.5000 x 0
Ask3.5000 x 0
Day's range4.5000 - 4.5000
52-week range2.0100 - 4.5000
Volume5,000
Avg. volume12,015
Market capN/A
Beta (5Y monthly)N/A
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • GlobeNewswire

    Hofseth Biocare ASA: NOTICE OF ANNUAL GENERAL MEETING 2024

    The Annual General Meeting of Hofseth BioCare ASA for 2024 will be held at the company's premises at Keiser Wilhelms gate 24, 6003 Ålesund, on 10 May 2024 at 13:00 CET. The notice of the Annual General Meeting is attached. For further information, please contact: Jon Olav Ødegård, CEO of Hofseth BioCare ASA Phone: +47 93632966 E-mail: investor@hofsethbiocare.no About Hofseth BioCare ASA: HBC is a Norwegian consumer and pet health ingredient supplier and an incubator for new pharmaceutical drug l

  • GlobeNewswire

    Hofseth Biocare ASA: HBC ANNUAL REPORT 2023

    The Board of Directors of Hofseth BioCare ASA ("HBC") has approved the financial statements for 2023 and the Company has today published the Annual Report and Sustainability Report for 2023. Please find the Annual Report and ESG Report attached. For further information, please contact:Christel Elise Kanli, CFO of Hofseth BioCare ASAPhone: +47 41623188E-mail: ck@hofsethbiocare.no About Hofseth BioCare ASA: HBC is a Norwegian consumer and pet health ingredient supplier and an incubator for new pha

  • GlobeNewswire

    Hofseth Biocare ASA: UPDATED COMPANY PRESENTATION

    Please find the HBC Company Presentation attached. For further information, please contact: James Berger, Chief Commercial Officer of Hofseth BioCare ASA Phone: +41 79 950 10 34 E-mail: jb@hofsethbiocare.no About Hofseth BioCare ASA: HBC is a Norwegian consumer and pet health ingredient supplier and an incubator for new pharmaceutical drug leads. Research is ongoing to identify the individual elements within its ingredients that modulate inflammation and the immune response with pre-clinical stu